Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Hammes HP; Du X; Edelstein D; Taguchi T; Matsumura T; Ju Q; Lin J; Bierhaus A; Nawroth P; Hannak D; Neumaier M; Bergfeld R; Giardino I; Brownlee M; Nature Medicine, 2003, vol. 9, issue 3, p 294, ISSN 10788956. ISBN 10788956.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef